Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis

Hepatology. 2003 May;37(5):1154-64. doi: 10.1053/jhep.2003.50180.

Abstract

Activation of macrophages by endotoxin is assumed responsible for increased circulating tumor necrosis factor alpha (TNF-alpha) and soluble TNF receptor (sTNFR) levels in cirrhosis. Relevant to this is expression of Toll-like receptor (TLR) 4 and TLR2, which is critically involved in production of TNF-alpha in response to endotoxin and Gram-positive microbial stimuli, respectively. The first studies on this in cirrhosis are reported here. In 36 cirrhotic patients and 32 controls, we measured (1) circulating endotoxin, TNF-alpha, and sTNFR levels; (2) peripheral blood mononuclear cell (PBMC) expression of TLR4 and TLR2, and (3) in vitro TNF-alpha production by PBMCs stimulated with endotoxin or Staphylococcus aureus enterotoxin B (SEB). PBMC expression of TLR2, circulating TNF-alpha levels, and in vitro TNF-alpha production were reassessed after supplementation with a synbiotic regimen known to increase intestinal levels of Gram-positive bacteria. Endotoxin, TNF-alpha, and sTNFR levels were significantly increased in cirrhosis. Endotoxin levels did not correlate significantly with other parameters. PBMC expression of TLR2 but not TLR4 was significantly up-regulated in cirrhosis and correlated significantly with serum TNF-alpha and sTNFR levels. In vitro TNF-alpha production by PBMCs stimulated by SEB was significantly blunted. Supplementation with the synbiotic regimen resulted in significant up-regulation of PBMC expression of TLR2. Serum TNF-alpha levels were further increased and in vitro TNF-alpha production further reduced in most patients. In conclusion, up-regulation of PBMC expression of TLR2 but not TLR4 occurs in cirrhosis, which implies, contrary to previous assumptions, an important stimulatory role for Gram-positive microbial components but not endotoxin. TLR2 likely contributes to increased circulating TNF-alpha and sTNFR levels in cirrhosis.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Drosophila Proteins*
  • Endotoxins / blood
  • Etanercept
  • Female
  • Gastrointestinal Agents / administration & dosage
  • Gram-Positive Bacteria
  • Humans
  • Immunoglobulin G / blood*
  • In Vitro Techniques
  • Lactulose / administration & dosage
  • Leukocytes, Mononuclear / physiology*
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / immunology
  • Male
  • Membrane Glycoproteins / metabolism*
  • Middle Aged
  • Probiotics / administration & dosage
  • Receptors, Cell Surface / metabolism*
  • Receptors, Tumor Necrosis Factor / blood*
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Drosophila Proteins
  • Endotoxins
  • Gastrointestinal Agents
  • Immunoglobulin G
  • Membrane Glycoproteins
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • TLR2 protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha
  • Lactulose
  • Etanercept